Phio Pharmaceuticals Corp. is a biotechnology company focused on developing innovative RNA-based therapeutics. With a strong track record in RNAi and oligonucleotide technologies, they aim to address unmet medical needs in oncology, genetic diseases, and autoimmune disorders. Advancing several promising candidates, Phio Pharmaceuticals is poised to make a significant impact in the field.
